Acutus Medical, Inc. (AFIB)

NASDAQ: AFIB · IEX Real-Time Price · USD
0.910
+0.004 (0.42%)
At close: Dec 9, 2022 4:00 PM
0.950
+0.040 (4.40%)
After-hours: Dec 9, 2022 4:11 PM EST
0.42%
Market Cap 25.78M
Revenue (ttm) 15.76M
Net Income (ttm) -85.99M
Shares Out 28.36M
EPS (ttm) -4.48
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 95,770
Open 0.91
Previous Close 0.906
Day's Range 0.87 - 0.93
52-Week Range 0.48 - 4
Beta 1.11
Analysts Buy
Price Target 3.57 (+292.3%)
Earnings Date Nov 10, 2022

About AFIB

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and ... [Read more]

Industry Medical Devices
IPO Date Aug 6, 2020
Employees 338
Stock Exchange NASDAQ
Ticker Symbol AFIB
Full Company Profile

Financial Performance

In 2021, Acutus Medical's revenue was $17.26 million, an increase of 103.96% compared to the previous year's $8.46 million. Losses were -$117.68 million, 15.4% more than in 2020.

Financial Statements

Analyst Forecast

According to 12 analysts, the average rating for AFIB stock is "Buy." The 12-month stock price forecast is 3.57, which is an increase of 292.31% from the latest price.

Price Target
$3.57
(292.31% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping Catheter

The flagship 3D mapping catheter from Acutus Medical has been certified under the new European Medical Device Regulations The flagship 3D mapping catheter from Acutus Medical has been certified under th...

3 days ago - GlobeNewsWire

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CARLSBAD, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are...

1 week ago - GlobeNewsWire

Acutus Medical, Inc. (AFIB) Reports Q3 Loss, Tops Revenue Estimates

Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of 13.25% and 3.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

4 weeks ago - Zacks Investment Research

Acutus Medical Reports Third Quarter 2022 Financial Results

CARLSBAD, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are...

4 weeks ago - GlobeNewsWire

Acutus Medical to Announce Third Quarter 2022 Financial Results

CARLSBAD, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and tr...

1 month ago - GlobeNewsWire

Acutus Medical Announces Submission of Premarket Approval Application for AcQBlate Force Sensing Ablation Catheter & ...

CARLSBAD, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are...

1 month ago - GlobeNewsWire

SHAREHOLDER UPDATE: Glancy Prongay & Murray LLP Appointed Lead Counsel in Securities Class Action Against Acutus Medi...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces that it has been appointed Lead Counsel in the securities class action against Acutus Medical, Inc. (“Acutus” or the “Company”...

3 months ago - Business Wire

Acutus Medical to Announce Second Quarter 2022 Financial Results

CARLSBAD, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and tr...

4 months ago - GlobeNewsWire

Acutus Medical Announces Approval of its AcQMap System and AcQMap 3D Imaging and Mapping Catheter in Japan

Approval ushers in a new era of arrhythmia management in Japan through revolutionary non-contact imaging and diagnosis technology Approval ushers in a new era of arrhythmia management in Japan through r...

4 months ago - GlobeNewsWire

Acutus Medical Announces CEO Appointment and Preliminary Second Quarter Revenue Results

CARLSBAD, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are...

4 months ago - GlobeNewsWire

Acutus Medical Completes First Closing of Transaction with Medtronic and Debt Refinancing to Fund Strategic Growth Pr...

CARLSBAD, Calif., July 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are...

5 months ago - GlobeNewsWire

Why Is Acutus Medical (AFIB) Stock Up 100% Today?

AFIB stock traders are celebrating as the FDA clears its arrhythmia management product for commercialization. The post Why Is Acutus Medical (AFIB) Stock Up 100% Today?

5 months ago - InvestorPlace

Why Acutus Medical Shares Are Rallying Today?

Acutus Medical Inc (NASDAQ: AFIB) has launched an expanded suite of left-heart access products, including the AcQCross Qx system for use with the TruSeal and FXD delivery system for the Watchman LAAC De...

5 months ago - Benzinga

Acutus Medical Announces FDA Clearance, Commercial Launch of AcQCross™ Line Extension Compatible with Watchman™ Deliv...

Innovative Transseptal Access System Is First and Only to Feature Integrated Dilator and Needle to Reduce Exchanges Innovative Transseptal Access System Is First and Only to Feature Integrated Dilator a...

5 months ago - GlobeNewsWire

Acutus Medical completes enrollment in IDE trial with its AcQBlate® FORCE Sensing Ablation System

CARLSBAD, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today annou...

6 months ago - GlobeNewsWire

Acutus Medical, Inc. (AFIB) Reports Q1 Loss, Tops Revenue Estimates

Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of -1.01% and 29.39%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Acutus Medical Reports First Quarter 2022 Financial Results and CEO Transition

CARLSBAD, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are ...

6 months ago - GlobeNewsWire

Acutus Medical to Announce First Quarter 2022 Financial Results

CARLSBAD, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and t...

7 months ago - GlobeNewsWire

Acutus Medical Stock Soars On Debt Refinancing, Divestiture Of Left-Heart Access Portfolio

Acutus Medical Inc (NASDAQ: AFIB) shares are skyrocketing on a commitment letter from Deerfield Management Company to refinance its existing debt with a new longer-term credit facility. The Company has ...

7 months ago - Benzinga

Acutus Medical Announces Agreements to Fund Strategic Growth Priorities

CARLSBAD, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias ar...

7 months ago - GlobeNewsWire

AFIB DEADLINE TODAY: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors to Secure Counsel B...

New York, New York--(Newsfile Corp. - April 18, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13...

7 months ago - Newsfile Corp

Deadline Today: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to Contact t...

Los Angeles, California--(Newsfile Corp. - April 18, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acutus Medical, Inc. ...

7 months ago - Newsfile Corp

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Acutus Investors of a Lead Plaintiff Deadline of April 18,...

NEW YORK , April 18, 2022 /PRNewswire/ -- Attention Acutus Medical, Inc. ("Acutus") (NASDAQ: AFIB) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on beh...

7 months ago - PRNewsWire

FINAL DEADLINE MONDAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors with Losses Over $1...

New York, New York--(Newsfile Corp. - April 16, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13...

7 months ago - Newsfile Corp

Deadline Monday Notice: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to C...

Los Angeles, California--(Newsfile Corp. - April 15, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acutus Medical, Inc. ...

7 months ago - Newsfile Corp